Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000049

Options or other derivatives

  • EVP, Chf Clinical Develop Ofcr acquired 31,545 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schneider Eugene · EVP, Chf Clinical Develop Ofcr

Table II: Derivative

2 lines
Date Transaction Shares Exercise Underlying Owned after D/I
2023-01-15 Grant or award : show line 1 in the form Performance Restricted Stock Units +14,338 $0.00 14,338 26,437 D
2023-01-15 Grant or award : show line 2 in the form Restricted Stock Unit +17,207 $0.00 17,207 53,116 D
Loading xslF345X03/edgardoc.xml…